CureVac

settlement lawsuit litigation
Pharma

GSK nabs $320M in CureVac patent settlement

The chapter on Pfizer and BioNTech’s mRNA patent feud with CureVac is ending, even as lawsuits over the technology continue to play out elsewhere.
Fraiser Kansteiner Aug 8, 2025 10:46am
BioNTech
Favicon Fierce Biotech

BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal

Jun 12, 2025 8:17am
A gavel in the foreground with the scale of justice in the background

CureVac takes a legal loss as German court invalidates patent

Dec 19, 2023 1:36pm
CureVac

CureVac touts 'progress' in vaccine patent case against BioNTech

Sep 28, 2023 2:45pm
CureVac

CureVac expands COVID-19 patent cases against Pfizer, BioNTech

Jul 13, 2023 11:36am
money scales

Pfizer and BioNTech contest CureVac COVID shot patent charges

Jul 26, 2022 9:45am